PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,896,932 | -18.3% | 764,367 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $9,661,978 | +23.4% | 736,993 | +5.3% | 0.00% | 0.0% |
| Q1 2023 | $7,827,587 | +140683.9% | 700,142 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $5,560 | -99.9% | 659,596 | +4.8% | 0.00% | -50.0% |
| Q3 2022 | $10,485,000 | +17.5% | 629,374 | +3.8% | 0.00% | +100.0% |
| Q2 2022 | $8,925,000 | -33.3% | 606,332 | +12.5% | 0.00% | -50.0% |
| Q1 2022 | $13,372,000 | -22.7% | 538,992 | -0.1% | 0.00% | 0.0% |
| Q4 2021 | $17,307,000 | -7.2% | 539,692 | +4.1% | 0.00% | -33.3% |
| Q3 2021 | $18,657,000 | +34.2% | 518,539 | +64.5% | 0.00% | +50.0% |
| Q2 2021 | $13,905,000 | +47.6% | 315,178 | +53.0% | 0.00% | +100.0% |
| Q1 2021 | $9,423,000 | -31.5% | 206,026 | +3.3% | 0.00% | -50.0% |
| Q4 2020 | $13,762,000 | – | 199,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |